nedaplatin
Sign in to saveNedaplatin, sold in Japan as Aqupla (see External Links), is a platinum-based chemotherapy agent. It is toxic to DNA, causing damage to DNA, limiting DNA repair and ultimately limiting DNA synthesis, limiting the propagation of cancer cells.
Research
955 papers- [Nedaplatin].Gan to kagaku ryoho. Cancer & chemotherapy · 1996
- Hypersensitivity reaction to nedaplatin: A case report and literature review.Medicine · 2023
- Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis.Scientific reports · 2015
- Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin.Taiwanese journal of obstetrics & gynecology · 2020
- Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study).International journal of surgery (London, England) · 2024
via PubMed
Wikidata facts
- Has part
- hydrogen
- Mass
- 305.033933
- Has use
- medication
Show 3 more facts
- chemical formula
- C₂H₁₀N₂O₃Pt
- subject has role
- antineoplastic
- canonical SMILES
- C(C(=O)O)O.N.N.[Pt]
via Wikidata · CC0
~8 min read
Encyclopedic overview
14 sectionsContents
- Medical uses
- Available forms
- Adverse effects
- Toxicity
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Chemistry
- Structure
- Reactivity
- Synthesis
- History
- References
- External links
Nedaplatin, sold in Japan as Aqupla (see External Links), is a platinum-based chemotherapy agent. It is toxic to DNA, causing damage to DNA, limiting DNA repair and ultimately limiting DNA synthesis, limiting the propagation of cancer cells.
== Medical uses == Nedaplatin can be prescribed to patients with the following types of cancer: small/non-small cell lung cancer oesophageal cancer uterine cervical cancer urothelial cancer testicular cancer ovarian cancer prostate cancer head and neck cancer
Excerpted from Wikipedia’s “nedaplatin” article, available under the CC BY-SA 4.0 licence.
Available in 9 languages
via Wikidata sitelinks · CC0